Welcoming eLabNext to SoCal | The Digital Transformation of the Modern Lab
Join us for a special event at Hero House Glendale as we officially welcome eLabNext, part of the Eppendorf Group, to Southern California.
As the life sciences industry continues to embrace digital transformation, we are thrilled to partner with eLabNext to drive this conversation forward. The event will feature a panel discussion with experts from eLabNext (part of Eppendorf Group), Bayer, and Modicus Prime on the topic of challenges and opportunities presented by digital transformation in the life sciences industry.
Panel Discussion
Moderator: Zareh Zurabyan, Head of eLabNext, Americas division of Eppendorf
Speakers: Erwin Seinen, Founder and Managing Director of eLabNext, Mehdi Saghafi, Principal Biotech Data Engineer at Bayer Pharmaceuticals, and Taylor Chartier, Founder and CEO of Modicus Prime.
Startup Booths
If you are a biotech company founder looking to showcase your startup to potential investors and clients, apply for booth space here: http://bit.ly/3Jn4gHd
Attendees can expect to learn about the latest developments in life science labs, image analysis, and data aggregation, meet promising biotech startups, and network with industry experts over drinks and food.
The event is co-organized by SmartGateVC and eLabNext:
SmartGateVC is a SoCal- and Armenia-based pre-seed and seed venture capital firm investing at the intersection of AI with healthcare, biotech, security and IoT across Southern California, wider U.S. and Armenia.
Hero House by SmartGateVC is a startup and innovation hub. It connects science, technology, entrepreneurship and capital, fostering the creation and advancement of new ventures.
eLabNext, part of the Eppendorf Group, specializes in lab digitization to enhance life science research and development. The company's Digital Lab Platform and support team assist clients throughout their digitization journey, helping them make breakthroughs in fields such as cancer research, sustainable food production, and COVID-19 vaccines. With eLabNext's solutions, clients can take advantage of the increasing benefits of digitizing R&D workflows.
